Czechia, July 1 -- Czechia based Bristol-Myers Squibb spol. s r.o. has secured contract from Institut klinicke a experimentalni mediciny for Immunosuppressive agents - Selective immunosuppressive agents - Belatacept II . The value of the contract is worth 146601500 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....